Annovis Bio Inc (ANVS) Annual Balance Sheets

Annual · GAAP · USD millions
Access ANVS quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Annovis Bio Inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent19.53
Cash & Short-term Investments19.00
Other Current Assets0.00
Total Current Assets21.08
Other Assets, Noncurrent0.00
Prepaid Expense Security Deposits And Other Assets Current1.55
Total Assets21.08
Liabilities
Accounts Payable, Current AC2.59
Other Liabilities, Current0.00
Total Current Liabilities3.64
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Accrued Liabilities And Interest And Employee Related Liabilities Current1.04
Warrant Liability Noncurrent0.60
Total Liabilities4.23
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock180.55
Retained Earnings / Accumulated Deficit-163.70
Other Equity0.00
Common Stockholder's Equity16.85
Total Stockholder's Equity16.85
Liabilities & Stockholder's Equity21.08
4 historic quarters locked

Sign in to unlock the full Annovis Bio Inc balance sheet history.

About Annovis Bio Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-027751

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License